I love the concept of their anti-cancer drugs. My question is , I want to invest long term. I do not want to trade it.Do you think that now is a good entry point or should I wait a while to after a secondary . I know we have time before human trials begin.
Most traders buy and sell stocks in anticipation of where the stock should be valued at six months down the road. Six months is about the time needed for Antares to finally begin its long anticipated evolution into a revenue producing small pharmaceutical growth company. I believe from about this time forward we will finally start seeing Antares stock price begin to steadily rise. GLT
Antares has become a small and growing pharmaceutical company with its own sales force. It also is about to have its first generic drug be approved by the FDA.In other words be patient and we will be rewarded.Remember
we are talking about a $2.5 dollar stock.
The price movement over the last couple of weeks reminds of stocks that I have owned that were bought out.Looks to me like there are some buy-out rumors out there.
Pfizer sees injectables and biosimilars as large and growing market with estimated $70 billion market by 2020. ATRS is undervalued big time with that time of market on the horizon
Who cares ? News already factored into stock price